These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4323527)

  • 21. [Trials of vaccination ff swine against foot-and-mouth disease virus type O with a live vaccine obtained through mouse brain passage].
    Benndorf E
    Arch Exp Veterinarmed; 1966 Mar; 20(1):151-6. PubMed ID: 4293435
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evolution and duration of anti-aphthous immunity in the primo-vaccinated ox].
    Lucam F; Fedida M; Dannacher G; Perraud J
    Bull Off Int Epizoot; 1969; 71(3-4):463-84. PubMed ID: 4324720
    [No Abstract]   [Full Text] [Related]  

  • 23. [Characterization of the antibodies inhibiting complement fixation in the sera of cattle immunized with an anti-aphthous vaccine].
    Hessami M; Roumiantzeff M; Salvatori J; Caillere F
    Bull Off Int Epizoot; 1969; 71(3-4):443-62. PubMed ID: 4101093
    [No Abstract]   [Full Text] [Related]  

  • 24. Fast modification of foot-and-mouth disease virus by selecting clones in bovines.
    Bernal C; Balestrini J; Gomez G; Castañeda J
    Dev Biol Stand; 1976; 35():471-9. PubMed ID: 198313
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnosis and control of bovine enzootic leukosis. 4. Comparison of antibody formation following inoculation of the Riems concentrated foot-and-mouth disease vaccine in clinicially healthy and in pre-leukotic cattle].
    Seils H; Wittmann W; Weyhe D
    Arch Exp Veterinarmed; 1971 Jun; 25(3):581-6. PubMed ID: 4330772
    [No Abstract]   [Full Text] [Related]  

  • 26. [Correaation between the sero-neutralization test in mice and crossed anti-aphthous immunization in cattle].
    Bercan A; Muntiu N; Dohotaru V; Tomescu A
    Bull Off Int Epizoot; 1969; 71(3-4):381-92. PubMed ID: 4323526
    [No Abstract]   [Full Text] [Related]  

  • 27. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
    Warrington RE; Cunliffe HR; Bachrach HL
    Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
    [No Abstract]   [Full Text] [Related]  

  • 28. [Several criteria of evaluation of foot-and-mouth disease virus reproduced in cell cultures in suspension].
    Girard HC
    Dev Biol Stand; 1976; 35():91-6. PubMed ID: 71255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide vaccine--a new approach to a safer foot-and-mouth disease virus vaccine.
    Pfaff E; Thiel HJ; Böhm HO; Leban J
    Arzneimittelforschung; 1987 Jan; 37(1):82-6. PubMed ID: 3032213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further information on the survival of modified foot-and-mouth disease virus in cattle.
    Augé de Mello P; Honigman MN; Fernandes MV; Gomes I
    Bull Off Int Epizoot; 1970; 73(5):489-505. PubMed ID: 4337797
    [No Abstract]   [Full Text] [Related]  

  • 31. Utilization and control of BHK cells in inactivated foot-and-mouth disease vaccine production.
    Capstick PB; Telling RC; Garland AJ
    Prog Immunobiol Stand; 1967; 3():131-5. PubMed ID: 4314421
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of virus infection-associated antigen and 3D antibodies in cattle vaccinated against foot and mouth disease.
    O'Donnell VK; Smitsaart E; Cetra B; Duffy S; Finelli J; Boyle D; Draghi G; Fondevila N; Schudel AA
    Rev Sci Tech; 1997 Dec; 16(3):833-40. PubMed ID: 9567309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An experimental subunit vaccine for foot-and-mouth disease.
    Bachrach HL; Moore DM; McKercher PD; Polatnick J
    Dev Biol Stand; 1976; 35():155-60. PubMed ID: 198282
    [No Abstract]   [Full Text] [Related]  

  • 34. The influence of aluminium hydroxide content, dose volume and the inclusion of saponin on the efficacy of inactivated foot-and-mouth disease vaccines.
    Hyslop NS; Morrow AW
    Res Vet Sci; 1969 Mar; 10(2):109-20. PubMed ID: 5818030
    [No Abstract]   [Full Text] [Related]  

  • 35. [Attempted vaccination of swine with inactive aphthous virus vaccines. I. Tests of O virus inactivated with hydroxylamine, formol, heat and pH].
    Wittmann G; Bauer K; Mussgay M
    Bull Off Int Epizoot; 1969; 71(3-4):351-79. PubMed ID: 4323525
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunologic relations between the foot-and-mouth disease virus isolates A5 Westerwald 1951 and A5 Bernbeuren 1984].
    Bengelsdorff HJ
    Berl Munch Tierarztl Wochenschr; 1987 Aug; 100(8):264-8. PubMed ID: 2820373
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunochemical studies of foot-and-mouh disease. IX. Differences in neutralizing activities of guinea pig and bovine 19S and 7S antibodies.
    Wagner GG; Cown KM
    J Immunol; 1971 Mar; 106(3):656-60. PubMed ID: 4323129
    [No Abstract]   [Full Text] [Related]  

  • 38. [Testing of the activity of anti-foot-and-mouth disease vaccines].
    Fédida M; Dannacher G; Coudert M; Perrin M; Martel JL
    Dev Biol Stand; 1976; 35():243-70. PubMed ID: 198292
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study in the Razi Institute of foot-and-mouth disease virus strains isolated in the Middle East from 1962 to 1967. Influence on the control of foot-and-mouth disease].
    Rafyi A; Santucci J; Kaveh M; Giraud M; Arshadi M; Gilbert H; Amighi M; Stellmann C; Mastan B; Fontaine J; Aminzadeh M; Roumiantzeff M; Chafyi A; Favre H; Hessami M
    Bull Off Int Epizoot; 1968; 69(1):57-74. PubMed ID: 4301803
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study of the immunity in swine vaccinated with type C anti-foot-and-mouth disease vaccine].
    Tekerlekov P; Mitev G; Antov A; Gergov P
    Vet Med Nauki; 1976; 13(8):56-61. PubMed ID: 193242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.